Best in Biotech 4 Nov 2022 Get to know 15 of the best biotech companies in Paris …based vaccines. OSE’s most advanced treatment is a therapeutic vaccine that consists of a combination of nine fragments of cancer antigens that stimulate T cells to attack cancer cells that… November 4, 2022 - 11 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 Apr 2024 Chicago biotech: Seven players advancing the industry …therapeutic platform that leverages the patient’s own regulatory T cells to treat solid organ transplant recipients and individuals with autoimmune disorders. This innovative approach aims to establish immune tolerance and… April 2, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Interview 11 Sep 2018 How To Break Into The Crowded Immuno-Oncology Space …like for the clinician and the patient trying to get access to that product. That might sound like a simple thing to say, but while clinicians in the hematological centers… September 11, 2018 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2018 CAR-T Promise for Patients with Solid Tumors …is a procedure in which a patient’s immune T cells are modified to produce proteins on their surface that let them hunt cancer cells. The cells then get injected back… November 14, 2018 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 23 Nov 2023 The next frontier in immunotherapy? CAR-Macrophages as a novel cancer treatment strategy …tumor microenvironment (TME) and prevent immune cells from effectively responding. It is an area where conventional treatments, be it checkpoint inhibitors or CAR-T cell therapies, struggle to gain traction. CAR-T… November 23, 2023 - 5 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jan 2025 The in vivo revolution: How Interius, Umoja, and Vyriad are transforming CAR-T cell therapy …1 trial for Interius BioTherapeutics’ in vivo CAR gene therapy INT2104 The investigational therapy INT2104 is a single dose that is delivered intravenously to patients. It is designed to target… January 10, 2025 - 5 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Startup Scout 16 Aug 2019 This Biotech Fights Alzheimer’s Disease by Targeting Support Brain Cells …by targeting the protein amyloid-beta. Reynolds told me that, while amyloid-beta is likely important in the early stages of Alzheimer’s disease, it could be too late to target this protein… August 16, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 9 Feb 2017 Alma Bio Therapeutics is Aiming to Revolutionize the Treatment of IBD …closer to a Treg vaccine that recognizes a patient’s specific repertoire of self-antigens: it distinguishes between these and the “correct” ones to act only when required. To us, our technology… February 9, 2017 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 10 Nov 2022 SOTIO reveal potential treatment for adults with solid tumors at SITC meeting …therapy has made significant strides in the treatment of hematological malignancies, yet solid tumors remain resistant to current CAR-T strategies due to suppression by the tumor microenvironment. “The preclinical data… November 10, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 25 Dec 2024 When biotech makes Christmas miracles a reality …explore alternative options. They turned to trametinib, a drug initially developed to treat melanoma. This targeted therapy inhibits MEK1 and MEK2, proteins that play a crucial role in the MAPK/ERK… December 25, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 Sep 2021 The top 15 biotech companies to find in the Netherlands …top of chemotherapy. Lava Therapeutics Founded: 2016 Lava Therapeutics develops cancer immunotherapies that use antibodies to recruit gamma-delta T cells – a type of immune cells that are naturally involved… September 2, 2021 - 7 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 30 Sep 2019 €20M Series A Launches Cancer Immunotherapy Biotech in Denmark …tumor cells. This signal then tells immune cells in the tumor microenvironment to attack the tumor. STipe’s treatments are designed to make the immune cells’ STING alarm signal more sensitive… September 30, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email